Pfizer Inc. elected COO Albert Bourla to its board, effective Feb. 23.
Prior to his appointment as COO, Bourla was the group president of Pfizer Innovative Health.
Discover more about S&P Global’s offerings
Pfizer adds COO to board
Essential IR Insights Newsletter Fall - 2023
A Corporation Clearly Pinpoints Activist Investor Activity
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Pfizer Inc. elected COO Albert Bourla to its board, effective Feb. 23.
Prior to his appointment as COO, Bourla was the group president of Pfizer Innovative Health.